Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentMarieke Biegstraaten, Carla E. M. Hollak, Franco Cecchi et al.|Orphanet Journal of Rare Diseases|2015Cited by 345
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase DeficiencyBarbara K. Burton, Anthony Quinn, Manisha Balwani et al.|New England Journal of Medicine|2015Cited by 244